Mechanisms of docetaxel resistance in prostate cancer: The key role played by miRNAs.
作者： Milena Rizzo
DOI: 10.1016/J.BBCAN.2020.188481
关键词: microRNA 、 Taxane 、 Internal medicine 、 Docetaxel 、 Positive response 、 Docetaxel resistance 、 Medicine 、 Oncology 、 Drug resistance 、 Prostate cancer
摘要: … to docetaxel, the … docetaxel resistance and non-coding RNA seems to play a relevant role in them. In this review, a comprehensive overview of the miRNA network involved in docetaxel …
sci-hub.st 参考文章(161)
Biao Dong, Zhihao Shi, Jiaping Wang, Jing Wu, Zhaoqing Yang, Kewei Fang, IL-6 Inhibits the Targeted Modulation of PDCD4 by miR-21 in Prostate Cancer PLOS ONE. ,vol. 10, ,(2015) , 10.1371/JOURNAL.PONE.0134366
Yaxiong Tang, Basmina Parmakhtiar, Anne R. Simoneau, Jun Xie, John Fruehauf, Michael Lilly, Xiaolin Zi, Lycopene enhances docetaxel's effect in castration-resistant prostate cancer associated with insulin-like growth factor I receptor levels. Neoplasia. ,vol. 13, pp. 108- 119 ,(2011) , 10.1593/NEO.101092
Julie Y. Djeu, Sheng Wei, Clusterin and Chemoresistance Advances in Cancer Research. ,vol. 105, pp. 77- 92 ,(2009) , 10.1016/S0065-230X(09)05005-2
Guanyi Zhang, Xichun Liu, Jianzhuo Li, Elisa Ledet, Xavier Alvarez, Yanfeng Qi, Xueqi Fu, Oliver Sartor, Yan Dong, Haitao Zhang, Androgen receptor splice variants circumvent AR blockade by microtubule-targeting agents Oncotarget. ,vol. 6, pp. 23358- 23371 ,(2015) , 10.18632/ONCOTARGET.4396
Lateef A Muhammad, Fred Saad, The role of clusterin in prostate cancer: treatment resistance and potential as a therapeutic target. Expert Review of Anticancer Therapy. ,vol. 15, pp. 1049- 1061 ,(2015) , 10.1586/14737140.2015.1064769
Emmanuel S Antonarakis, Changxue Lu, Brandon Luber, Hao Wang, Yan Chen, Mary Nakazawa, Rosa Nadal, Channing J Paller, Samuel R Denmeade, Michael A Carducci, Mario A Eisenberger, Jun Luo, None, Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer JAMA Oncology. ,vol. 1, pp. 582- 591 ,(2015) , 10.1001/JAMAONCOL.2015.1341
Irene V. Bijnsdorp, Reindert J.A. Van Moorselaar, Daniela E. Oprea-Lager, Otto S. Hoekstra, Albert A. Geldof, Alfons J.M. Van Den Eertwegh, ABCC4 Decreases docetaxel and not cabazitaxel efficacy in prostate cancer cells in vitro. Anticancer Research. ,vol. 33, pp. 387- 391 ,(2013)
Hiroki Tamaki, Nanae Harashima, Miho Hiraki, Naoko Arichi, Nobuhiro Nishimura, Hiroaki Shiina, Kohji Naora, Mamoru Harada, Bcl-2 family inhibition sensitizes human prostate cancer cells to docetaxel and promotes unexpected apoptosis under caspase-9 inhibition Oncotarget. ,vol. 5, pp. 11399- 11412 ,(2014) , 10.18632/ONCOTARGET.2550
S Terry, G Ploussard, Y Allory, N Nicolaiew, F Boissiere-Michot, P Maille, L Kheuang, E Coppolani, A Ali, F Bibeau, S Culine, R Buttyan, A De La Taille, F Vacherot, None, Increased expression of class III β -tubulin in castration-resistant human prostate cancer British Journal of Cancer. ,vol. 101, pp. 951- 956 ,(2009) , 10.1038/SJ.BJC.6605245
E S Antonarakis, A J Armstrong, Evolving standards in the treatment of docetaxel-refractory castration-resistant prostate cancer Prostate Cancer and Prostatic Diseases. ,vol. 14, pp. 192- 205 ,(2011) , 10.1038/PCAN.2011.23